MediWound Statistics

Total Valuation

MediWound has a market cap or net worth of $172.38 million. The enterprise value is $136.15 million.

Market Cap	172.38M
Enterprise Value	136.15M

Important Dates

The last earnings date was Wednesday, March 19, 2025, before market open.

Earnings Date	Mar 19, 2025
Ex-Dividend Date	n/a

Share Statistics

MediWound has 10.81 million shares outstanding. The number of shares has increased by 10.50% in one year.

Current Share Class	10.81M
Shares Outstanding	10.81M
Shares Change (YoY)	+10.50%
Shares Change (QoQ)	+2.66%
Owned by Insiders (%)	1.68%
Owned by Institutions (%)	43.19%
Float	7.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.86
Forward PS	6.62
PB Ratio	5.53
P/TBV Ratio	5.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.73
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.97, with a Debt / Equity ratio of 0.22.

Current Ratio	1.97
Quick Ratio	1.85
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-36.88

Financial Efficiency

Return on equity (ROE) is -96.33% and return on invested capital (ROIC) is -31.74%.

Return on Equity (ROE)	-96.33%
Return on Assets (ROA)	-17.33%
Return on Invested Capital (ROIC)	-31.74%
Return on Capital Employed (ROCE)	-41.32%
Revenue Per Employee	$182,180
Profits Per Employee	-$272,288
Employee Count	111
Asset Turnover	0.29
Inventory Turnover	6.35

Taxes

In the past 12 months, MediWound has paid $61,000 in taxes.

Income Tax	61,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.63% in the last 52 weeks. The beta is 0.82, so MediWound's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	+5.63%
50-Day Moving Average	17.96
200-Day Moving Average	17.62
Relative Strength Index (RSI)	40.30
Average Volume (20 Days)	82,582

Short Selling Information

Short Interest	906,570
Short Previous Month	933,201
Short % of Shares Out	9.82%
Short % of Float	n/a
Short Ratio (days to cover)	12.97

Income Statement

In the last 12 months, MediWound had revenue of $20.22 million and -$30.22 million in losses. Loss per share was -$3.03.

Revenue	20.22M
Gross Profit	2.63M
Operating Income	-19.40M
Pretax Income	-12.55M
Net Income	-30.22M
EBITDA	-18.58M
EBIT	-19.40M
Loss Per Share	-$3.03

Full Income Statement

Balance Sheet

The company has $43.16 million in cash and $6.93 million in debt, giving a net cash position of $36.23 million or $3.35 per share.

Cash & Cash Equivalents	43.16M
Total Debt	6.93M
Net Cash	36.23M
Net Cash Per Share	$3.35
Equity (Book Value)	31.15M
Book Value Per Share	2.89
Working Capital	25.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.62 million and capital expenditures -$6.27 million, giving a free cash flow of -$19.90 million.

Operating Cash Flow	-13.62M
Capital Expenditures	-6.27M
Free Cash Flow	-19.90M
FCF Per Share	-$1.84

Full Cash Flow Statement

Margins

Gross margin is 13.03%, with operating and profit margins of -95.94% and -149.46%.

Gross Margin	13.03%
Operating Margin	-95.94%
Pretax Margin	-149.16%
Profit Margin	-149.46%
EBITDA Margin	-91.89%
EBIT Margin	-95.94%
FCF Margin	n/a

Dividends & Yields

MediWound does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.50%
Shareholder Yield	n/a
Earnings Yield	-17.53%
FCF Yield	-11.54%

Analyst Forecast

The average price target for MediWound is $32.00, which is 100.63% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.00
Price Target Difference	100.63%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	46.65%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 20, 2022. It was a reverse split with a ratio of 0.1428571:1.

Last Split Date	Dec 20, 2022
Split Type	Reverse
Split Ratio	0.1428571:1

Scores

MediWound has an Altman Z-Score of -1.78 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.78
Piotroski F-Score	1